Sarepta Therapeutics Inc. (SRPT)
Market Closed
3 Sep, 20:00
$
22. 99
-0.22
-0.9479%
$
2.22B Market Cap
- P/E Ratio
- Div Yield
2.77M Volume
-6.99 Eps
$ 23.21
Previous Close 
Want to track SRPT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Sarepta Therapeutics Inc. (SRPT) Statistics
Valuation metrics
Market Cap 2.22B
Enterprise value 2.68B
Trailing P/E (ttm) -14.49
Forward P/E 6.76
PEG ratio 0.02
Price/Sales (ttm) 1.12
Price/Book (mrq) 1.44
Enterprise Value/Revenue 1.36
Enterprise Value/EBITDA -183.56
Overview
Shares outstanding 104.96M
Float 91.78M
Shares short 25.33M
% Held by insiders 0.05%
% Held by institutions 0.9%
Average volume (10 days) 3.61M
Average volume (90 days) 3.94M
Price summary
52-Week low 14.68
52-Week high 25.32
Beta 0.28
50-Day moving average 16.9
200-Day moving average 18.74
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:6
Last split Date 12 Jul 2012
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -0.07%
Operating margin -0.07%
Operational effectiveness
Return on assets -0.04%
Return on equity -0.1%
Income Statement
Revenue (ttm) 2.2B
Revenue per share (ttm) 18.73
Quarterly revenue growth (yoy) -0.33%
Gross profit (ttm) -163.43M
EBITDA -613.25M
Net income to common (ttm) -713.41M
Diluted EPS (ttm) -1.3
Quarterly earnings growth (yoy) -0.33%
Balance Sheet
Total cash (mrq) 939.65M
Total cash per share (mrq) 7.48
Total debt (mrq) 1.04B
Total Debt/Equity (mrq) 0.68
Current ratio (mrq) 4.42%
Book value per share (mrq) 14.49
Cash Flow
Cash flow statement -205.48M
Levered free cash flow (LFCF) 95.92M
